Artificial intelligence (AI), particularly deep learning models, are often considered black boxes because their ...
Oruka analysis: ultra-durable psoriasis biologics ORKA-001/002 aim for 1–3 doses/yr with strong efficacy; liquid balance ...
Kyverna Therapeutics, Inc. shares surged on strong Phase 2 KYSA-8 data for Miv-cel in stiff person syndrome, supporting a bullish outlook. KYTX's Miv-cel achieved significant clinical improvements and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback